期刊
AMERICAN JOURNAL OF BIOETHICS
卷 22, 期 2, 页码 4-22出版社
ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
DOI: 10.1080/15265161.2020.1867933
关键词
Enhancement; genetics (clinical); health policy; reproductive technologies
The availability of prenatal genetic testing for a wide range of diseases raises questions about access to genetic information. The authors argue that parents should have access to useful information during pregnancy, but non-medical testing should be limited. They propose that regulation should be done through medical professional organizations instead of government and provide a framework for determining which tests should be recommended or offered.
Prenatal genetic testing is becoming available for an increasingly broad set of diseases, and it is only a matter of time before parents can choose to test for hundreds, if not thousands, of genetic conditions in their fetuses. Should access to certain kinds of fetal genetic information be limited, and if so, on what basis? We evaluate a range of considerations including reproductive autonomy, parental rights, disability rights, and the rights and interests of the fetus as a potential future child. We conclude that parents should be able to access information that could be useful during pregnancy, but that testing for non-medical information should be limited. Next, we argue that the government lacks a compelling state interest in regulating prenatal genetic testing and propose that regulation should occur through medical professional organizations. Finally, we present a framework for determining what testing physicians should recommend, offer neutrally, or not offer at all.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据